Cargando…
Effect of an Electronic Alert System on Hepatitis B Virus Reactivation in Patients Receiving Immunosuppressive Drug Therapy
Hepatitis B virus (HBV) reactivation (HBVr) can occur in patients receiving immunosuppressive drug therapies, causing significant morbidity and mortality. Although the guidelines for HBVr have been proposed by several academic societies, some providers do not follow them, resulting in HBVr and death...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9104084/ https://www.ncbi.nlm.nih.gov/pubmed/35566572 http://dx.doi.org/10.3390/jcm11092446 |
_version_ | 1784707708346171392 |
---|---|
author | Asai, Akira Hirai, Saho Yokohama, Keisuke Nishikawa, Tomohiro Nishikawa, Hiroki Higuchi, Kazuhide |
author_facet | Asai, Akira Hirai, Saho Yokohama, Keisuke Nishikawa, Tomohiro Nishikawa, Hiroki Higuchi, Kazuhide |
author_sort | Asai, Akira |
collection | PubMed |
description | Hepatitis B virus (HBV) reactivation (HBVr) can occur in patients receiving immunosuppressive drug therapies, causing significant morbidity and mortality. Although the guidelines for HBVr have been proposed by several academic societies, some providers do not follow them, resulting in HBVr and death. As HBV-DNA levels increase before liver enzyme levels do, we previously constructed an electronic alert system that recommends the measurement of HBV-DNA. Here, we investigated whether this alert system improves the HBV-DNA measurement rate and elicits responses according to guidelines. A total of 5329 patients were divided into two groups, before and after the introduction of the alert system, and the HBV-DNA measurement rates in both groups were compared. Because of the introduction of the alert system, the HBV-DNA measurement rate among HBsAg-negative patients with anti-HBs and/or anti-HBc before immunosuppressive drug therapy improved significantly. The HBV-DNA monitoring rate within 3 months also improved significantly (p = 0.0034) in HBV-remission phase patients. HBVr was detected immediately, and the affected patients were treated with nucleotide analogs before severe hepatitis onset. The introduction of the alert system for HBVr improved the HBV-DNA measurement rates in patients receiving immunosuppressive drug therapy, leading to the rapid treatment of patients with HBVr. |
format | Online Article Text |
id | pubmed-9104084 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-91040842022-05-14 Effect of an Electronic Alert System on Hepatitis B Virus Reactivation in Patients Receiving Immunosuppressive Drug Therapy Asai, Akira Hirai, Saho Yokohama, Keisuke Nishikawa, Tomohiro Nishikawa, Hiroki Higuchi, Kazuhide J Clin Med Article Hepatitis B virus (HBV) reactivation (HBVr) can occur in patients receiving immunosuppressive drug therapies, causing significant morbidity and mortality. Although the guidelines for HBVr have been proposed by several academic societies, some providers do not follow them, resulting in HBVr and death. As HBV-DNA levels increase before liver enzyme levels do, we previously constructed an electronic alert system that recommends the measurement of HBV-DNA. Here, we investigated whether this alert system improves the HBV-DNA measurement rate and elicits responses according to guidelines. A total of 5329 patients were divided into two groups, before and after the introduction of the alert system, and the HBV-DNA measurement rates in both groups were compared. Because of the introduction of the alert system, the HBV-DNA measurement rate among HBsAg-negative patients with anti-HBs and/or anti-HBc before immunosuppressive drug therapy improved significantly. The HBV-DNA monitoring rate within 3 months also improved significantly (p = 0.0034) in HBV-remission phase patients. HBVr was detected immediately, and the affected patients were treated with nucleotide analogs before severe hepatitis onset. The introduction of the alert system for HBVr improved the HBV-DNA measurement rates in patients receiving immunosuppressive drug therapy, leading to the rapid treatment of patients with HBVr. MDPI 2022-04-26 /pmc/articles/PMC9104084/ /pubmed/35566572 http://dx.doi.org/10.3390/jcm11092446 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Asai, Akira Hirai, Saho Yokohama, Keisuke Nishikawa, Tomohiro Nishikawa, Hiroki Higuchi, Kazuhide Effect of an Electronic Alert System on Hepatitis B Virus Reactivation in Patients Receiving Immunosuppressive Drug Therapy |
title | Effect of an Electronic Alert System on Hepatitis B Virus Reactivation in Patients Receiving Immunosuppressive Drug Therapy |
title_full | Effect of an Electronic Alert System on Hepatitis B Virus Reactivation in Patients Receiving Immunosuppressive Drug Therapy |
title_fullStr | Effect of an Electronic Alert System on Hepatitis B Virus Reactivation in Patients Receiving Immunosuppressive Drug Therapy |
title_full_unstemmed | Effect of an Electronic Alert System on Hepatitis B Virus Reactivation in Patients Receiving Immunosuppressive Drug Therapy |
title_short | Effect of an Electronic Alert System on Hepatitis B Virus Reactivation in Patients Receiving Immunosuppressive Drug Therapy |
title_sort | effect of an electronic alert system on hepatitis b virus reactivation in patients receiving immunosuppressive drug therapy |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9104084/ https://www.ncbi.nlm.nih.gov/pubmed/35566572 http://dx.doi.org/10.3390/jcm11092446 |
work_keys_str_mv | AT asaiakira effectofanelectronicalertsystemonhepatitisbvirusreactivationinpatientsreceivingimmunosuppressivedrugtherapy AT hiraisaho effectofanelectronicalertsystemonhepatitisbvirusreactivationinpatientsreceivingimmunosuppressivedrugtherapy AT yokohamakeisuke effectofanelectronicalertsystemonhepatitisbvirusreactivationinpatientsreceivingimmunosuppressivedrugtherapy AT nishikawatomohiro effectofanelectronicalertsystemonhepatitisbvirusreactivationinpatientsreceivingimmunosuppressivedrugtherapy AT nishikawahiroki effectofanelectronicalertsystemonhepatitisbvirusreactivationinpatientsreceivingimmunosuppressivedrugtherapy AT higuchikazuhide effectofanelectronicalertsystemonhepatitisbvirusreactivationinpatientsreceivingimmunosuppressivedrugtherapy |